1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. GAIN THERAPEUTICS INC
Gain Therapeutics Inc
XNAS: GANX
Download real time
1.64 0.02 (1.23%)
62.21% Fall from 52W High
327.6K
XNAS Volume

XNAS 09 Oct, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert


Insider Trading disclosures for Gain Therapeutics Inc

The latest disclosure was made by Ms. Gwen A. Melincoff in Gain Therapeutics Inc where a trade of 25,000 Stock Option (right to buy) done was reported to US exchanges on July 15, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Ms. Gwen A. Melincoff Director 15 Jul 2026 25,000 25,000 - - Stock Option (right to buy)
Dr. Khalid Islam, PhD Director 15 Jul 2026 25,000 25,000 - - Stock Option (right to buy)
Dr. Claude Nicaise,M.D. Director 15 Jul 2026 25,000 25,000 - - Stock Option (right to buy)
Mr. Hans Peter Hasler Director 15 Jul 2026 25,000 25,000 - - Stock Option (right to buy)
Dr. Dov A. Goldstein, M.B.A.,M.D. Director 15 Jul 2026 25,000 25,000 - - Stock Option (right to buy)
Mr. Gianluca Fuggetta See Remark 24 Mar 2026 50,000 50,000 - - Employee Stock Option (right to buy)
Mr. Gene Mack Director, CEO, President 24 Mar 2026 200,000 200,000 - - Employee Stock Option (right to buy)
Ms. Gwen A. Melincoff Director 24 Jun 2025 15,000 15,000 - - Stock Option (right to buy)
Dr. Khalid Islam, PhD Director 24 Jun 2025 15,000 15,000 - - Stock Option (right to buy)
Dr. Claude Nicaise,M.D. Director 24 Jun 2025 15,000 15,000 - - Stock Option (right to buy)
Mr. Hans Peter Hasler Director 24 Jun 2025 15,000 15,000 - - Stock Option (right to buy)
Dr. Dov A. Goldstein, M.B.A.,M.D. Director 24 Jun 2025 15,000 15,000 - - Stock Option (right to buy)
Mr. Eric I. Richman Director 24 Jun 2025 15,000 15,000 - - Stock Option (right to buy)
Mr. Gene Mack Director, CEO, President 20 Mar 2025 200,000 200,000 - - Employee Stock Option (right to buy)
Mr. Gianluca Fuggetta See Remark 20 Mar 2025 50,000 50,000 - - Employee Stock Option (right to buy)
Mr. Gene Mack Director, CEO, President 06 Jan 2025 271,325 271,325 - - Stock Option (right to buy)
Mr. Gene Mack CFO and Interim CEO Purchase of securities on an exchange or from another person at price $ 1.01 per share. 09 Aug 2024 14,400 14,400 - 1.0 14,544 Common Stock
Dr. Khalid Islam, PhD Director, Executive Chairman Purchase of securities on an exchange or from another person at price $ 1.00 per share. 09 Aug 2024 50,000 50,000 - 1.0 49,940 Common Stock
Mr. Eric I. Richman Director Purchase of securities on an exchange or from another person at price $ 1.23 per share. 01 Jul 2024 5,000 277,629 - 1.2 6,150 Common Stock
Mr. Eric I. Richman Director Purchase of securities on an exchange or from another person at price $ 1.21 per share. 01 Jul 2024 12,000 289,629 - 1.2 14,520 Common Stock
Dr. Dov A. Goldstein, M.B.A.,M.D. Director 24 Jun 2024 15,000 15,000 - - Stock Option (right to buy)
Dr. Claude Nicaise,M.D. Director 24 Jun 2024 15,000 15,000 - - Stock Option (right to buy)
Mr. Hans Peter Hasler Director 24 Jun 2024 15,000 15,000 - - Stock Option (right to buy)
Dr. Khalid Islam, PhD Director 24 Jun 2024 15,000 15,000 - - Stock Option (right to buy)
Ms. Gwen A. Melincoff Director 24 Jun 2024 15,000 15,000 - - Stock Option (right to buy)
Mr. Eric I. Richman Director 24 Jun 2024 15,000 15,000 - - Stock Option (right to buy)
Mr. Gene Mack Chief Financial Officer 08 Apr 2024 200,000 200,000 - - Employee Stock Option (right to buy)
Mr. Matthias Alder Director, Chief Executive Officer 26 Mar 2024 825 8,250 - - Restricted Stock Units
Mr. Matthias Alder Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Mar 2024 18,750 25,763 - - Common Stock
Mr. Matthias Alder Director, Chief Executive Officer 26 Mar 2024 637 6,376 - - Restricted Stock Units
Mr. Matthias Alder Director, Chief Executive Officer 26 Mar 2024 18,750 56,250 - - Restricted Stock Units
Mr. Matthias Alder Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Mar 2024 825 26,588 - - Common Stock
Mr. Matthias Alder Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Mar 2024 637 27,225 - - Common Stock
Mr. Matthias Alder Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.06 per share. 26 Mar 2024 6,085 21,140 - 4.1 24,705 Common Stock
Mr. Matthias Alder Director, Chief Executive Officer 21 Mar 2024 370,000 370,000 - - Employee Stock Option (right to buy)
Mr. Gianluca Fuggetta See Remark 21 Mar 2024 50,000 50,000 - - Employee Stock Option (right to buy)
Mr. Matthias Alder Director, Chief Executive Officer 20 Dec 2023 637 7,013 - - Restricted Stock Units
Mr. Matthias Alder Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 2.46 per share. 20 Dec 2023 206 5,286 - 2.5 507 Common Stock
Mr. Matthias Alder Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Dec 2023 637 5,492 - - Common Stock
Mr. Matthias Alder Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 2.50 per share. 07 Dec 2023 1,820 4,855 - 2.5 4,550 Common Stock
Mr. Matthias Alder Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Oct 2023 825 6,675 - - -
Mr. Matthias Alder Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Oct 2023 825 6,675 - - -
Mr. Eric I. Richman Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Sep 2023 54,900 272,629 - - -
Mr. Matthias Alder Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Sep 2023 2,550 5,850 - - -
Mr. Matthias Alder Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Sep 2023 2,550 5,850 - - -
Mr. Matthias Alder Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2023 3,300 3,300 - - Common Stock
Mr. Matthias Alder Director, Chief Executive Officer 01 Jul 2023 3,300 9,900 - - Restricted Stock Units
Ms. Gwen A. Melincoff Director 23 Jun 2023 10,500 10,500 - - Stock Option (right to buy)
Dr. Khalid Islam Director 23 Jun 2023 10,500 10,500 - - Stock Option (right to buy)
Dr. Claude Nicaise,M.D. Director 23 Jun 2023 10,500 10,500 - - Stock Option (right to buy)
Mr. Hans Peter Hasler Director 23 Jun 2023 10,500 10,500 - - Stock Option (right to buy)
Dr. Dov A. Goldstein, M.D. Director 23 Jun 2023 10,500 10,500 - - Stock Option (right to buy)
Mr. C. Evan Ballantyne Chief Financial Officer 10 Apr 2023 50,000 50,000 - - Restricted Stock Units
Mr. C. Evan Ballantyne Chief Financial Officer 10 Apr 2023 100,000 100,000 - - Employee Stock Option (right to buy)
Mr. Salvatore Calabrese Chief Financial Officer 23 Mar 2023 25,000 25,000 - - Restricted Stock Units
Mr. Gianluca Fuggetta Principal Accounting Officer 23 Mar 2023 15,000 15,000 - - Employee Stock Option (right to buy)
Mr. Matthias Alder Director, Chief Executive Officer 23 Mar 2023 150,000 150,000 - - Employee Stock Option (right to buy)
Mr. Matthias Alder Director, Chief Executive Officer 23 Mar 2023 75,000 75,000 - - Restricted Stock Units
Mr. Salvatore Calabrese Chief Financial Officer 23 Mar 2023 50,000 50,000 - - Employee Stock Option (right to buy)
Mr. Eric I. Richman Director 20 Sep 2022 329,400 329,400 - - Employee Stock Option (right to buy)
Mr. Eric I. Richman Director 20 Sep 2022 54,900 54,900 - - Restricted Stock Units
Dr. Dov A. Goldstein, M.D. Director 20 Sep 2022 10,500 10,500 - - Stock Option (right to buy)
Mr. Matthias Alder Director, Chief Operating Officer 20 Sep 2022 60,900 60,900 - - Employee Stock Option (right to buy)
Mr. Matthias Alder Director, Chief Operating Officer 20 Sep 2022 10,200 10,200 - - Restricted Stock Units
Ms. Gwen A. Melincoff Director 20 Sep 2022 10,500 10,500 - - Stock Option (right to buy)
Dr. Khalid Islam Director 20 Sep 2022 10,500 10,500 - - Stock Option (right to buy)
Dr. Claude Nicaise,M.D. Director 20 Sep 2022 10,500 10,500 - - Stock Option (right to buy)
Mr. Hans Peter Hasler Director 20 Sep 2022 10,500 10,500 - - Stock Option (right to buy)
Mr. Salvatore Calabrese Chief Financial Officer 15 Jul 2022 9,900 9,900 - - Restricted Stock Units
Mr. Matthias Alder Chief Operating Officer 15 Jul 2022 13,200 13,200 - - Restricted Stock Units
Mr. Matthias Alder Chief Operating Officer 15 Jul 2022 79,200 79,200 - - Employee Stock Option (right to buy)
Mr. Salvatore Calabrese Chief Financial Officer 15 Jul 2022 59,400 59,400 - - Employee Stock Option (right to buy)
Mr. Eric I. Richman Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.58 per share. 25 May 2022 2,482 217,729 - 2.6 6,404 Common stock
Mr. Eric I. Richman Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.83 per share. 19 May 2022 9,256 215,247 - 2.8 26,194 Common Stock
Mr. Salvatore Calabrese CHIEF FINANCIAL OFFICER Purchase of securities on an exchange or from another person at price $ 8100.00 per share. 19 May 2022 3,000 - - 8100 24,300,000 -
Mr. Eric I. Richman Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.71 per share. 19 May 2022 4,000 205,991 - 2.7 10,840 Common stock
Mr. Salvatore Calabrese CHIEF FINANCIAL OFFICER Purchase of securities on an exchange or from another person at price $ 8100.00 per share. 19 May 2022 3,000 - - 8100 24,300,000 -
Mr. Salvatore Calabrese CHIEF FINANCIAL OFFICER Purchase of securities on an exchange or from another person at price $ 2.70 per share. 19 May 2022 3,000 3,000 - 2.7 8,100 Common Stock
Mr. Matthias Alder CHIEF OPERATING OFFICER 23 Dec 2021 200,000 200,000 - - Non Qualified Stock Option (right to buy)
Mr. Eric I. Richman Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.87 per share. 16 Aug 2021 4,922 216,820 - 7.9 38,716 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters